Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Ghana MHL Project in Tamale is a study focused on helping pregnant women improve their nutrition by teaching them about local foods. The goal is to encourage mothers to eat a wider variety of foods that are rich in protein, energy, and iron, which are important for both their health and the health of their babies. This program was developed with the help of pregnant women and health experts in the community to ensure it meets their needs. Researchers want to see how this nutrition education impacts mothers’ understanding of healthy eating and how it affects the health of their babies.
To be part of this study, participants need to be first-time pregnant mothers aged 18 to 40 who are in their second trimester (between 16 and 20 weeks of pregnancy) and have a lower body mass index (BMI). Women who are having complications or who are further along in their pregnancy, as well as those who do not plan to give birth in the area, are not eligible to participate. While the study is not yet recruiting participants, those who join can expect to learn valuable nutrition information that may help them and their babies during this important time.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Nulliparous pregnant (first-time) mothers (BMI\<20kg/m2) between the ages of 18 and 40 attending antenatal sessions and in their second trimester, gestational ages (GA) of 16 weeks to 20 weeks, who are not carrying multiple fetuses
- Exclusion Criteria:
- • Women with pregnancies greater than 20 weeks gestation, to ensure adequate exposure to the intervention; mothers presenting with significant morbidity or who are admitted due to complications and mothers who cannot confirm an address or contact information and do not plan to deliver at a health facility as well as those who indicate that they would not deliver in the study region (those who will be out of town at time of delivery).
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tamale, Northern Region, Ghana
Patients applied
Trial Officials
Ruthfirst EA Ayande, PhD, MSc, RD
Principal Investigator
Yale University
Gloria E Otoo, PhD
Principal Investigator
University of Ghana
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported